Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BioCardia Inc
BCDA | US
1.28
USD0.10
8.47%
BCDA | US
Loading StockChartView...
About BioCardia Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
1.28
Open
1.18
High
1.32
Low
1.15
BioCardia Inc. a clinical-stage regenerative medicine company engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform an investigational culture expanded bone marrow derived mesenchymal cell therapy which is in Phase I/II trial for the treatment of ischemic heart failure. In addition it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale California.
View LessBCDA | US
Risk
62.3
Sharpe
-0.63
Luna's Score
42/100
Recommendation
Sell
Luna says (BCDA | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
75.2%1 month
62.3%3 months
60.9%6 months
87.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
10.67
Debt to equity
-0.58
Debt to assets
0.39
Ent. to EBITDA
-3.16
Ent. to rev.
20.90
PEG
-
Other Fundamentals
EBITDA
-8.53M
MarketCap
4.48M
MarketCap(USD)
4.48M
Div. yield
-
Op. margin
-54.97K
Erngs. growth
-
Rev. growth
-93.00
Ret. on equity
-703.62
Short ratio
0.22
Short perc.
4.06
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.29
Range1M
0.29
Range3M
0.41
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
3.14
Price X volume
291.29K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.16 | 0.53 | Cheaper |
| Ent. to Revenue | 20.90 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 10.67 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 60.85 | 72.80 | Par |
| Debt to Equity | -0.58 | -1.23 | Expensive |
| Debt to Assets | 0.39 | 0.25 | Expensive |
| Market Cap | 4.48M | 3.66B | Emerging |
